TRUST CO OF VERMONT - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19
-74.0%
2040.0%0.00%
Q2 2023$730.0%2040.0%0.00%
Q1 2023$73
-59.7%
2040.0%0.00%
Q4 2022$1812040.0%0.00%
Q3 2022$02040.0%0.00%
Q2 2022$0
-100.0%
2040.0%0.00%
Q4 2021$1,000
-50.0%
2040.0%0.00%
Q2 2021$2,0000.0%2040.0%0.00%
Q1 2021$2,000
+100.0%
2040.0%0.00%
Q4 2020$1,000
-50.0%
2040.0%0.00%
Q3 2020$2,0002040.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,623,533$22,851,0006.45%
Avoro Capital Advisors LLC 1,146,579$9,987,0003.44%
Cormorant Asset Management, LP 2,095,334$18,250,0002.18%
Healthcare Value Capital, LLC 50,000$436,0000.72%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$174,0000.25%
SABBY MANAGEMENT, LLC 300,000$2,613,0000.14%
STRATEGIC INVESTMENT MANAGEMENT, LLC 20,398$177,0000.10%
Granite Investment Partners, LLC 89,622$781,0000.07%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 54,634$476,0000.06%
Trexquant Investment LP 67,929$592,0000.05%
View complete list of SORRENTO THERAPEUTICS INC shareholders